跳至主要内容
临床试验/NCT01271764
NCT01271764已完成不适用

The Association of G9a Protein and Outcome of Patients With Endometrial Cancer

Far Eastern Memorial Hospital2 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
97
试验地点
2
主要终点
The role of G9a protein in endometrial cancer

研究概览

简要总结

Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • all cases with endometrial cancer underwent staging operation

排除标准

  • 未提供

结局指标

主要结局

The role of G9a protein in endometrial cancer

时间窗: overall survial, disease-free survival

We will correlate the G9a protein and outcome of endometrial cancer

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheng-Mou Hsiao

Chief, Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

研究点 (2)

Loading locations...

相似试验